Page last updated: 2024-12-05

ethylamphetamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethylamphetamine: RN given refers to parent cpd with unspecified isomeric designation; see also record for d-N-ethylamphetamine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9982
CHEMBL ID276443
CHEBI ID134796
SCHEMBL ID162316
MeSH IDM0066397

Synonyms (47)

Synonym
benzeneethanamine, n-ethyl-.alpha.-methyl-
n-ethylamphetamine
NCI60_004353
benzeneethanamine, n-ethyl-alpha-methyl-
etilanfetamina [spanish]
apetinil
etilamfetaminum [latin]
ethylamphetamine
etilamfetamine [inn]
etilamfetaminum [inn-latin]
phenethylamine, n-ethyl-alpha-methyl-
n-ethyl-alpha-methylphenethylamine
alpha-phenyl-beta-ethylaminopropane
1-phenyl-2-aethylamino-propan [german]
etilamfetamina [inn-spanish]
dea no. 1475
brn 2357701
1-phenyl-2-ethylaminopropane
etilamfetamine
457-87-4
etilamfetamine (inn)
D07114
CHEBI:134796
n-ethyl-1-phenylpropan-2-amine
CHEMBL276443
022yon1xmx ,
1-phenyl-2-aethylamino-propan
etilamfetamina
etilamfetaminum
etilanfetamina
unii-022yon1xmx
ethylamphetamine [who-dd]
n-ethylamphetamine [mi]
n-ethyl-.alpha.-methylphenethylamine
AKOS017343299
SCHEMBL162316
n-ethyl-.omega.-phenylisopropylamine
phenethylamine, n-ethyl-.alpha.-methyl-
2-ethylamino-1-phenylpropane
YAGBSNMZQKEFCO-UHFFFAOYSA-N
.alpha.-phenyl-.beta.-ethylaminopropane
n-ethyl-1-phenyl-2-propanamine #
dl-n-ethylamphetamine
DTXSID10860359
Q5404591
DB13285
benzeneethanamine, n-ethyl-alpha-methyl- (9ci)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"8% of the administered dosage of dl-EAMP (5."( Analysis of time-lapse changes of d- and l-enantiomers of racemic ethylamphetamine and stereoselective metabolism in rat urine by HPLC determination.
Kamiyama, S; Matsushima, K; Nagai, T,
)
0.37
"The time-lapse changes of d- and i-forms in urine specimens collected in the 24 h after the oral dosing of two adult male subjects with 20 mg of racemic (dl)-ethylamphetamine (EAMP)-HCl were examined by high-performance liquid chromatography."( Time-lapse changes of d- and l-enantiomers of racemic (dl)-ethylamphetamine in human urine.
Kamiyama, S; Kanaya, H; Matsushima, K; Nagai, T,
)
0.57
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
amphetaminesAmines that constitute a class of central nervous system stimulants based on the structure of the parent amphetamine 1-phenylpropan-2-amine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (20.00)18.7374
1990's5 (33.33)18.2507
2000's3 (20.00)29.6817
2010's3 (20.00)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.06 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]